ProCE Banner Activity

ExpressPoints:
Advances in CAR-T Cell Therapy Across Hematologic Malignancies

Slideset Download
Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in the use of CAR T-cell therapy.

Released: December 20, 2021

Expiration: December 19, 2022

No longer available for credit.

Share

Faculty

Jesus G. Berdeja

Jesus G. Berdeja, MD

Director, Multiple Myeloma Program
Sarah Cannon Research Institute
Attending Physician
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Jae H. Park

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Jesus G. Berdeja, MD

Director, Multiple Myeloma Program
Sarah Cannon Research Institute
Attending Physician
Sarah Cannon Center for Blood Cancer
Tennessee Oncology
Nashville, Tennessee

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York